FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
This article was originally published in The Tan Sheet
Executive Summary
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over the control to receive agency approval, FDA told Pfizer execs at an Aug. 27 meeting